Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Pilot Study of Curcumin and Piperine to Derive a Safe, Optimal Biologic Dose for Ureteral Stent-Induced Symptoms in Cancer Patients

NCT02598726 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02598726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02598726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Pilot Study of Curcumin and Piperine to Derive a Safe, Optimal Biologic Dose for Ureteral Stent-Induced Symptoms in Cancer Patients
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2016
Completion date
September 19, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder spasm, malignant neoplasm, pain, urinary urgency